Skip to main content
Link to Homepage
IP Group plc
IP Group plc
Link to About us page Expand About us

About us.

Find out how we’re transforming ideas into impact at scale through the businesses we identify, back and grow.

Link to Our capabilities page
Link to Our story page
Link to Our partners page
Link to Our people page Expand Our people
Link to Board page
Link to Executive team page
Link to Our people page
about us
Annual Report 2024
Read our Annual Report and Accounts for the year ending 2024.
Download PDF
Link to Our portfolio page Expand Our portfolio

Our portfolio.

Link to Our focus areas page
Link to Case studies page
Annual Report
Annual Report 2024
Read our Annual Report and Accounts for the year ending 2024.
Download PDF
Link to Investors page Expand Investors

Investors.

We have a proven track-record in backing and nurturing science and technology-based businesses to deliver a better future for people and planet.

Link to Investment case page
Link to Results, reports and presentations page
Link to Regulatory news page
Link to Financial calendar page
Link to Share price information page Expand Share price information
Link to Share price information page
Link to Interactive chart page
Link to Calculator page
Link to Download page
Link to Shareholder information page Expand Shareholder information
Link to AGM / GM page
Link to Registrar page
Link to FAQs page
Link to Other information page
Link to Corporate governance page
Link to Analysts and advisors page Expand Analysts and advisors
Link to Analysts and advisors page
Link to Research page
Link to Contacts and alerts page
AR-2023
Annual Report 2024
Read our Annual Report and Accounts for the year ending 2024.
Download PDF
Link to Our impact page Expand Our impact

Our impact.

Find out how we’re living our purpose and identifying, backing and growing businesses that contribute to a healthier, tech-enriched, sustainable future.

Link to Governance and policies page
2021 Annual report
Impact Report
Read our Impact Report.
Download PDF
Link to Insights page
Link to News & Events page Expand News & Events

News & Events.

Link to IP Group news page
Link to Portfolio news page
Link to Events page
Annual Report 2022
Annual Report 2024
Read our Annual Report and Accounts for the year ending 2024.
Read More
  • Discover more
  • About us
    • Discover more
    • Our capabilities
    • Our story
    • Our partners
    • Our people
      • Board
      • Executive team
      • Our people
  • Our portfolio
    • Discover more
    • Our focus areas
    • Case studies
  • Investors
    • Discover more
    • Investment case
    • Results, reports and presentations
    • Regulatory news
    • Financial calendar
    • Share price information
      • Discover more
      • Interactive chart
      • Calculator
      • Download
    • Shareholder information
      • AGM / GM
      • Registrar
      • FAQs
      • Other information
    • Corporate governance
    • Analysts and advisors
      • Discover more
      • Research
    • Contacts and alerts
  • Our impact
    • Discover more
    • Governance and policies
  • Insights
  • News & Events
    • Discover more
    • IP Group news
    • Portfolio news
    • Events
  • Careers
  • Contact
Click here to open globe boxOur global sites
Click here to open search box

Open and close mobile menu

Search in site
  • Our portfolio

Backing the daring, rewarding the brave.

  • Top 10 holdings
  • Life Sciences
  • Deeptech
  • Cleantech
  • australasia
  • oxford nanopore technologies
  • strategic
  • Tech
  • united states

Portfolio
Overview:
PDF Excel Click here to open search box

Search in site
logo

IP Group holding: 9.5%*

Develops medicines for the treatment of primary mitochondrial diseases
  • Life Sciences
logo

IP Group holding: 26.4%*

Developing a high performance decoding solution for 5G mobile communication
  • Deeptech
Logo

IP Group holding: 39.2%*

3D printing quality monitoring
  • Deeptech
logo

IP Group holding: 6.7%*

Clinical stage oncology company based on a tumor-specific immuno-gene therapy platform
  • Life Sciences
logo

IP Group holding: 34.8%*

Medical devices to improve the safety, efficiency and outcomes of advanced surgical procedures
  • Life Sciences
logo

IP Group holding: 21.5%*

Next-generation technology for gastric disorders
  • Life Sciences
logo

IP Group holding: 34.0%*

Long-range and efficient eVTOL
  • Cleantech
Logo

IP Group holding: 7.1%*

Carbon capture and mineralization technology to reuse industrial wastes from the concrete industry
  • Cleantech
logo

IP Group holding: 24.6%*

Unique solutions for encapsulation based on cutting-edge research
  • Deeptech
logo

IP Group holding: 7.3%*

Novel oncology therapies that leverage the changes in the DNA Damage Response (DDR) in cancer cells
  • Top 10 holdings
  • Life Sciences
logo

IP Group holding: 34.0%*

Personalised, trackable 3D sound projection technology
  • Deeptech
logo

IP Group holding: 32.0%*

Novel heat exchanger technology
  • Cleantech
Load more61

*Holding percentages in portfolio companies reflect the undiluted beneficial equity interest excluding debt, unless otherwise explicitly stated.

Showing XX of 61

Load more
Load more
logo

IP Group holding: 9.5%*

Develops medicines for the treatment of primary mitochondrial diseases
  • Life Sciences
logo

IP Group holding: 26.4%*

Developing a high performance decoding solution for 5G mobile communication
  • Deeptech
Logo

IP Group holding: 39.2%*

3D printing quality monitoring
  • Deeptech
logo

IP Group holding: 6.7%*

Clinical stage oncology company based on a tumor-specific immuno-gene therapy platform
  • Life Sciences
logo

IP Group holding: 34.8%*

Medical devices to improve the safety, efficiency and outcomes of advanced surgical procedures
  • Life Sciences
logo

IP Group holding: 21.5%*

Next-generation technology for gastric disorders
  • Life Sciences
logo

IP Group holding: 34.0%*

Long-range and efficient eVTOL
  • Cleantech
Logo

IP Group holding: 7.1%*

Carbon capture and mineralization technology to reuse industrial wastes from the concrete industry
  • Cleantech
logo

IP Group holding: 24.6%*

Unique solutions for encapsulation based on cutting-edge research
  • Deeptech
logo

IP Group holding: 7.3%*

Novel oncology therapies that leverage the changes in the DNA Damage Response (DDR) in cancer cells
  • Top 10 holdings
  • Life Sciences
logo

IP Group holding: 34.0%*

Personalised, trackable 3D sound projection technology
  • Deeptech
logo

IP Group holding: 32.0%*

Novel heat exchanger technology
  • Cleantech
logo

IP Group holding: 31.6%*

The fuel cell company with Gigafactories
  • Cleantech
logo

IP Group holding: 0.9%*

Clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients
  • Life Sciences
logo

IP Group holding: 14.3%*

Immuno-oncology company developing novel, targeted T cell enhancing therapeutics
  • Life Sciences
Logo

IP Group holding: 14.6%*

Developing the next generation of image and video compression technology using an AI-first approach
  • Deeptech
logo

IP Group holding: 29.7%*

AI automation of computer code testing
  • Deeptech
logo

IP Group holding: 19.6%*

Novel disease modifying medications for respiratory disease
  • Life Sciences
logo

IP Group holding: 27.5%*

Solving fusion with the simplest possible machine.
  • Cleantech
  • Top 10 holdings
logo

IP Group holding: 9.7%*

Using large-scale genetic information to develop precision healthcare tools and to bring new understanding to drug discover
  • Life Sciences
logo

IP Group holding: 36.8%*

Mobile assessment and training platform for home-based upper limb rehabilitation
  • Life Sciences
logo

IP Group holding: 13.6%*

Perovskite-based light-emitting devices for next-gen displays
  • Deeptech
logo

IP Group holding: 1.7%*

Digital clinic for joint and muscle care
  • Life Sciences
  • Top 10 holdings
logo

IP Group holding: 37.0%*

Developing a new type of breakthrough hydrogen electrolyser and accelerating the global transition to net zero
  • Cleantech
  • Top 10 holdings
logo

IP Group holding: 35.9%*

Software for the early identification of osteoporosis from an X-ray image
  • Life Sciences
logo

IP Group holding: 12.6%*

Creating scalable, effective, and highly personalised digital mental health products
  • Life Sciences
logo

IP Group holding: 21.5%*

Next-generation antibody-drug conjugates (ADCs) for cancer therapy
  • Life Sciences
logo

IP Group holding: 26.0%*

Early-stage drug discovery using insulin-regulated aminopeptidase (IRAP) as a novel target in fibrosis
  • Life Sciences
logo

IP Group holding: 24.3%*

Silicon-based resistive random access memory (RRAM) technology
  • Deeptech
logo

IP Group holding: 56.5%*

From disease modification to disease resolution
  • Life Sciences
  • Top 10 holdings
logo

IP Group holding: 8.3%*

Novel polymers, e.g. "removable chewing gum"
  • Deeptech
logo

IP Group holding: 1.6%*

A holding company making impact investments in game-changing plant-based businesses
  • Cleantech
Logo

IP Group holding: 29.4%*

Software for optical neural networks
  • Deeptech
logo

IP Group holding: 50.0%*

Contactless, lubricant-free magnetic gear systems
  • Cleantech
Logo

IP Group holding: 15.4%*

Advanced geological-based prediction and detection technology to source natural hydrogen
  • Cleantech
logo

IP Group holding: 17.5%*

Microbiome based therapeutics and diagnostics
  • Life Sciences
logo

IP Group holding: 21.2%*

Drug development company targeting the ubiquitin pathway for the treatment of serious diseases
  • Life Sciences
  • Top 10 holdings
logo

IP Group holding: 22.6%*

Internet of Tanks reducing energy consumption and enabling renewables
  • Cleantech
logo

IP Group holding: 8.6%*

Focused on the discovery of a new generation of sustainable herbicides.
  • Life Sciences
logo

IP Group holding: 13.7%*

No-code AI for product engineering
  • Deeptech
logo

IP Group holding: 5.2%*

Silicon anodes for next generation lithium-ion batteries
  • Cleantech
  • Top 10 holdings
logo

IP Group holding: 11.8%*

Software to enable every vehicle to become autonomous
  • Cleantech
  • Top 10 holdings
logo

IP Group holding: 18.4%*

Catalyst to convert CO2 and Hydrogen into synthetic fuels
  • Cleantech
logo

IP Group holding: 27.3%*

Global leader in vision-based patient monitoring systems
  • Life Sciences
logo

IP Group holding: 8.7%*

Enabling the analysis of any living thing, by any person, in any environment using real-time DNA/RNA sequencing
  • Life Sciences
  • Top 10 holdings
logo

IP Group holding: 1.4%*

Achieving quantum computing through super conducting circuits
  • Deeptech
logo

IP Group holding: 1.5%*

Contractually preferred partner of the University of Oxford to develop spin-out companies based on divisional research
logo

IP Group holding: 11.8%*

Novel inhaled treatment for life-threatening fungal lung infections
  • Life Sciences
  • Top 10 holdings
logo

IP Group holding: 16.6%*

The world’s first compact completely embedded self-certified quantum random number generator
  • Deeptech
logo

IP Group holding: 7.3%*

Creating a scalable, high-density quantum computer on a silicon chip for the cloud
  • Deeptech
logo

IP Group holding: 19.0%*

Novel therapies for chronic respiratory inflammation
  • Life Sciences
logo

IP Group holding: 31.9%*

Developing the world’s lowest cost flow battery
  • Cleantech
Logo

IP Group holding: 19.7%*

Real-time monitoring of people and assets in harsh, dynamic environments
  • Deeptech
logo

IP Group holding: 13.8%*

Wireless, programmable construction kits for creative kids
  • Deeptech
logo

IP Group holding: 6.1%*

Visual tracking and mapping systems or 'Simultaneous Localisation and Mapping' (SLAM)
  • Deeptech
logo

IP Group holding: 12.1%*

Clinical stage biotechnology company creating novel therapies that inhibit RNA modifying enzymes for use in oncology
  • Life Sciences
logo

IP Group holding: 1.8%*

Smart home climate management and smart energy tariffs
  • Cleantech
logo

IP Group holding: -%*

Fast and secure payment solutions that can help businesses to better manage and grow their operations
  • Deeptech
logo

IP Group holding: 6.2%*

International medical technology company, focusing on the development of regenerative products
  • Life Sciences
logo

IP Group holding: 20.4%*

Removing boundaries between physical and digital worlds - for anyone, anywhere
  • Deeptech
logo

IP Group holding: 10.3%*

Reusable packing-as-a-service for food take-away and delivery
  • Cleantech
Link to homepage
IP Group plc
IP Group plc

Sign up

News alerts

Monthly newsletter

Quick links

  • Our story
  • Our portfolio
  • Investors
  • Our impact

Connect

Link to homepage
IP Group plc
IP Group plc

London

Hong Kong

Melbourne

  • © IP Group PLC 
  • Privacy
  • Disclaimer
  • Accessibility
  • Cookie
  • Cookie settings
  • Modern slavery statement
  • Site map

Annual Report Image

2024

Annual Report

Download PDF Investor relations
  • © IP Group PLC 
  • Privacy
  • Disclaimer
  • Accessibility
  • Cookie
  • Cookie settings
  • Modern slavery statement
  • Site map